Key advances in antihypertensive treatment

Area of Science:

• Cardiovascular Medicine
• Pharmacology
• Medical Devices

Background:

• Despite available treatments, hypertension management requires novel therapies for better blood pressure control and reduced cardiovascular risk.
• Resistant hypertension remains a significant clinical challenge necessitating innovative treatment strategies.

Purpose of the Study:

• To review emerging therapeutic approaches for hypertension, including pharmacological agents and device-based interventions.
• To highlight novel mechanisms of action and combination therapies for managing elevated blood pressure.

Main Methods:

• Review of recently approved and investigational antihypertensive drugs with novel mechanisms or dual activities.
• Analysis of new fixed-dose combination therapies for hypertension.
• Examination of device-based treatments for resistant hypertension, including renal denervation and baroreceptor activation therapy.

Main Results:

• Several novel drug classes targeting different pathways (aldosterone synthase, natriuretic peptides, etc.) are in development.
• New fixed-dose combinations of existing antihypertensives have been approved, with more anticipated.
• Device-based therapies like renal denervation show promise for resistant hypertension, while baroreceptor activation therapy requires further refinement.

Conclusions:

• A range of novel pharmacological and device-based treatments are emerging to address unmet needs in hypertension management.
• Further research and technical improvements are necessary for optimizing the safety and efficacy of some novel therapies, particularly device-based interventions.